Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Epiwil D 750mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Pifer Pharmaceuticals Pvt Ltd

Salt Composition

Divalproex (750mg)

Overview Epiwil D 750mg Tablet ER

Epileptic seizures and migraine prophylaxis are addressed by the extended-release formulation of Valproex 750mg tablets. This medication controls seizures and may also be prescribed for bipolar disorder management, sometimes in conjunction with other treatments. Dosage and frequency are determined individually by your physician to optimize symptom control. Administering this medication with or without food is acceptable, but maintaining consistent daily timing maximizes effectiveness. Therapeutic effects typically manifest within a couple of weeks. Consistent use, as directed, is crucial; discontinuation or missed doses risk seizure recurrence and condition exacerbation. Abrupt cessation is contraindicated. Common, generally mild, side effects include headache, visual blurring, nausea, vomiting, dizziness, fatigue, instability, easy bruising, and hypothermia. Persistent or bothersome side effects warrant medical consultation, while skin rashes demand immediate attention. Prolonged use may reduce bone density (osteoporosis), increasing fracture risk. Suicidal ideation and behavior are rare but serious potential side effects; report any mood changes to your physician immediately. Prior to initiating treatment, inform your physician about any history of cardiac issues, hepatic or renal impairment, urinary difficulties, depression, or suicidal thoughts. Drug interactions are possible; disclose all medications currently in use to ensure safety. Consult your doctor before altering medication use during pregnancy. Alcohol consumption should be minimized due to increased side effect and seizure risk. Regular blood tests may be necessary for dose monitoring, both initially and throughout treatment.

Uses of Epiwil D 750mg Tablet ER

Managing epilepsy and seizures | Bipolar disorder therapy | Migraine prevention

Major Benefits of Epiwil D 750mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epiwil D 750mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Epiwil D 750mg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Epiwil D 750mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epiwil D 750mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.

How Epiwil D 750mg Tablet ER works:

Epileptic seizures are managed by the extended-release anticonvulsant, Epiwil D 750mg Tablet ER. This medication reduces the hyperactivity of neurons in the brain, thus controlling convulsions.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Epiwil D 750mg extended-release tablets and alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Epiwil D 750mg tablets pose a confirmed risk to a developing fetus and should not be used during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Epiwil D 750mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Extended-release Epiwil D 750mg tablets can induce adverse reactions that may impair driving capabilities.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Epiwil D 750mg tablets are considered safe for use in individuals with impaired renal function. No alteration of the Epiwil D 750mg extended-release tablet dosage is necessary.

LiverLiverUNSAFE

Extended-release Epiwil D 750mg tablets pose a likely risk for individuals with hepatic impairment and should be omitted. Physician consultation is advised.

What if you forget to take Epiwil D 750mg Tablet ER :

Should you forget a dose of Epiwil D 750mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Epiwil D 750mg Tablet ER

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Type of Treatment Central Nervous System (CNS) Neurology
Active Class Anticonvulsant sodium channel blockers

FAQs on Epiwil D 750mg Tablet ER

Discontinue Epiwil D 750mg Tablet ER only under your doctor's guidance. Gradual dose reduction, overseen by a medical professional, is necessary to avoid potential withdrawal symptoms such as symptom recurrence, irritability, anxiety, dizziness, and tremors.
Yes, Epiwil D 750mg Extended-Release tablets may help stabilize mood in patients experiencing rapid mood swings. Its mechanism involves reducing excessive brain activity associated with these fluctuations.
Weight gain is a possible side effect of Epiwil D 750mg Tablet ER, potentially stemming from increased appetite. To minimize this, maintain a healthy diet and exercise routine. Consult your doctor if weight gain is a concern.
Drowsiness is a possible side effect of Epiwil D 750mg Extended-Release Tablets. Refrain from driving or operating machinery until you understand its effects on you.
Hair loss is a possible, though typically temporary and dose-dependent, side effect of Epiwil D 750mg Tablet ER. Contact your doctor if this side effect concerns you or continues.
Epiwil D 750mg Tablet ER can cause liver damage, particularly within the first six months of treatment. Symptoms such as nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes) may indicate liver injury. Liver function tests are crucial before starting and regularly during the initial six months, especially for high-risk individuals or those with pre-existing liver conditions.
Refrain from alcohol while taking Epiwil D 750mg Tablet ER. Consuming alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Epiwil D 750mg Tablet ER treatment, your doctor may order blood tests. These may include a complete blood count (with platelets), bleeding time, and coagulation studies to minimize bleeding risks. Liver function tests are also recommended before and, especially for high-risk individuals or those with a history of liver disease, during the first six months of treatment.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result requires immediate medication cessation.
Epiwil D 750mg ER tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Muscle weakness, seizures, unconsciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain may also occur. Seek immediate medical help if an overdose is suspected.
Epiwil D 750mg Tablet ER
103
MRP 125
17% off